Printed from https://ideas.repec.org/s/spr/eujhec2.html
Content
April 2023, Volume 24, Issue 3
- 479-481 Making the rules make sense: valuation of constrained resources
by Jonathan Siverskog - 483-483 Reply to: making the rules make sense: valuation of constrained resources
by Peter Lindgren
March 2023, Volume 24, Issue 2
- 153-156 General practice in the EU: countries you see, customs you find
by Livio Garattini & Marco Badinella Martini & Alessandro Nobili - 157-168 Survival analysis of cancer patients in Portugal following the reference centre model implementation
by Manuel Melo Mateus & Margarida Catalão-Lopes & Rui Portugal - 169-177 Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs
by Chiara Seghieri & Francesca Ferrè & Elisa Foresi & Alice Borghini - 179-186 Does a working day keep the doctor away? A critical review of the impact of unemployment and job insecurity on health and social care utilisation
by Keyi Li & Paula Lorgelly & Sarah Jasim & Tiyi Morris & Manuel Gomes - 187-196 Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
by Phil McEwan & James Baker-Knight & Björg Ásbjörnsdóttir & Yunni Yi & Aimee Fox & Robin Wyn - 197-207 Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China
by Guizhi Weng & Yanming Hong & Nan Luo & Clara Mukuria & Jie Jiang & Zhihao Yang & Sha Li - 209-236 The association between bed occupancy rates and hospital quality in the English National Health Service
by Laia Bosque-Mercader & Luigi Siciliani - 237-246 Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial
by Sun Sun & Håkan Jonsson & Klas-Göran Salén & Mats Andén & Lars Beckman & Per Fransson - 247-277 Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease
by B. Rodríguez-Sánchez & S. Daugbjerg & L. M. Peña-Longobardo & J. Oliva-Moreno & I. Aranda-Reneo & A. Cicchetti & J. López-Bastida - 279-292 Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg)
by Sun Sun & Erik Stenberg & Yang Cao & Lars Lindholm & Klas-Göran Salén & Karl A. Franklin & Nan Luo - 293-305 Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
by Stefan A. Lipman & Liying Zhang & Koonal K. Shah & Arthur E. Attema - 307-319 Understanding bias in probabilistic analysis in model-based health economic evaluation
by Xuanqian Xie & Alexis K. Schaink & Sichen Liu & Myra Wang & Andrei Volodin
February 2023, Volume 24, Issue 1
- 1-4 Patient-reported measures: how useful in health economics?
by Anne-Gaëlle Corroller & Julia Bonastre - 5-25 On absolute socioeconomic health inequality comparisons
by Mohamad A. Khaled & Paul Makdissi & Myra Yazbeck - 27-38 Health state utilities for beta-thalassemia: a time trade-off study
by Antony P. Martin & Enrico Ferri Grazzi & Claudia Mighiu & Manoj Chevli & Farrukh Shah & Louise Maher & Anum Shaikh & Aliah Sagar & Hayley Hubberstey & Bethany Franks & Juan M. Ramos-Goñi & Mark Oppe & Derek Tang - 39-52 Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic
by Jacques Bughin & Michele Cincera & Evelyn Kiepfer & Dorota Reykowska & Florian Philippi & Marcin Żyszkiewicz & Rafal Ohme & Dirk Frank - 53-66 Complexities of health and acceptance of electronic health records for the Austrian elderly population
by Nicole Halmdienst & Gerald J. Pruckner & Rudolf Winter-Ebmer - 67-74 The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies
by Florian Dorn & Sahamoddin Khailaie & Marc Stoeckli & Sebastian C. Binder & Tanmay Mitra & Berit Lange & Stefan Lautenbacher & Andreas Peichl & Patrizio Vanella & Timo Wollmershäuser & Clemens Fuest & Michael Meyer-Hermann - 75-80 Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
by G. Fabiano & A. Marcellusi & F. S. Mennini & P. Sciattella & G. Favato - 81-98 Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment
by Jonathan Sicsic & Serge Blondel & Sandra Chyderiotis & François Langot & Judith E. Mueller - 99-110 Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities
by Ignacio Amate-Fortes & Almudena Guarnido-Rueda - 111-123 The goal of risk equalization in regulated competitive health insurance markets
by Wynand Ven & Gerrit Hamstra & Richard Kleef & Mieke Reuser & Piet Stam - 125-138 Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands
by Chandeni S. Gajadien & Peter J. G. Dohmen & Frank Eijkenaar & Frederik T. Schut & Erik M. Raaij & Richard Heijink - 139-152 Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
by Kamilla Koszorú & Krisztina Hajdu & Valentin Brodszky & Alex Bató & L. Hunor Gergely & Anikó Kovács & Zsuzsanna Beretzky & Miklós Sárdy & Andrea Szegedi & Fanni Rencz
December 2022, Volume 23, Issue 9
- 1415-1436 Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries
by Brahim Gaies - 1437-1453 Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries
by Rudy Douven & Lukas Kauer & Sylvia Demme & Francesco Paolucci & Wynand Ven & Jürgen Wasem & Xiaoxi Zhao - 1455-1482 Determinants of willingness to pay for health services: a systematic review of contingent valuation studies
by Caroline Steigenberger & Magdalena Flatscher-Thoeni & Uwe Siebert & Andrea M. Leiter - 1483-1496 Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics
by Axel C. Mühlbacher & Andrew Sadler & Yvonne Jordan - 1497-1518 Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements
by Eduardo Costa & Carolina Santos - 1519-1533 Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014
by Laura Hirello & Mohammad Habibullah Pulok & Mohammad Hajizadeh - 1535-1545 The effect of informal caregiving on medication: evidence from administrative data
by Magdalena Stroka-Wetsch - 1547-1562 The attractiveness of jobs in the German care sector: results of a factorial survey
by Martin Kroczek & Jochen Späth - 1563-1575 Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database
by Zuzana Špacírová & David Epstein & Jaime Espín - 1577-1590 A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots
by Elahe Khorasani & Majid Davari & Abbas Kebriaeezadeh & Farshad Fatemi & Ali Akbari Sari & Vida Varahrami - 1591-1599 The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design
by Simona Gamba & Niklas Jakobsson & Mikael Svensson - 1601-1612 Looking into the black box of “Medical Innovation”: rising health expenditures by illness type
by Friedrich Breyer & Normann Lorenz & Gerald J. Pruckner & Thomas Schober - 1613-1615 Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
by Stefan A. Lipman & Liying Zhang & Koonal K. Shah & Arthur E. Attema
November 2022, Volume 23, Issue 8
- 1259-1261 Breaking the rules: decision-making under absolute resource constraints
by Peter Lindgren - 1263-1285 COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach
by Matthias Klumpp & Dominic Loske & Silvio Bicciato - 1287-1296 Value drivers of development stage biopharma companies
by Daniel Tobias Michaeli & Hasan Basri Yagmur & Timur Achmadeev & Thomas Michaeli - 1297-1308 Do we care about high-cost patients? Estimating the savings on health spending by integrated care
by Karen Geurts & Marc Bruijnzeels & Erik Schokkaert - 1309-1317 Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
by Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Mauskopf & C. Daniel Mullins & Stavros Petrou & Raoh-Fang Pwu & Sophie Staniszewska - 1319-1328 Does the abolition of copayment increase ambulatory care utilization?: a quasi-experimental study in Germany
by Mingming Xu & Benjamin Bittschi - 1329-1340 The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations
by Wiebke Schuettig & Leonie Sundmacher - 1341-1355 Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above
by Zsombor Zrubka & Péter Vékás & Péter Németh & Ágota Dobos & Ottó Hajdu & Levente Kovács & László Gulácsi & Judith Hibbard & Márta Péntek - 1357-1369 Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data
by Aileen R. Neilson & Gareth T. Jones & Gary J. Macfarlane & Ejaz MI Pathan & Paul McNamee - 1371-1381 Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
by Daniela Zinzi & Ioanna Vlachaki & Edel Falla & Theo Mantopoulos & Dilip Nathwani - 1383-1395 Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis
by Jiaer Lin & Carlos King Ho Wong & Jason Pui Yin Cheung & Prudence Wing Hang Cheung & Nan Luo - 1397-1411 Does voluntary health insurance improve health and longevity? Evidence from European OECD countries
by Simona Laura Dragos & Codruta Mare & Cristian Mihai Dragos & Gabriela Mihaela Muresan & Alexandra-Anca Purcel - 1413-1413 Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review
by Nazim Bhimani & Geoffrey Y. M. Wong & Charles Molloy & Mbathio Dieng & Patrick J. Kelly & Thomas J. Hugh
September 2022, Volume 23, Issue 7
- 1079-1083 Challenges for health systems seeking to embrace virtual health care for population health
by Panos Kanavos & Michelle Vogelsang & Madeleine Haig & Vasiliki Kolovou - 1085-1104 Defining minimum volume thresholds to increase quality of care: a new patient-oriented approach using mixed integer programming
by Justus F. A. Vogel & Max Barkhausen & Christoph M. Pross & Alexander Geissler - 1105-1119 Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in Ethiopia
by Abraham G. Welie & Elly Stolk & Clara Mukuria & Yared Belete Belay & Murray D. Krahn & Beate Sander & Gebremedhin Beedemariam Gebretekle - 1121-1149 Ageing and health care expenditures: the importance of age per se, steepening of the individual-level expenditure curve, and the role of morbidity
by Anna Kollerup & Jakob Kjellberg & Rikke Ibsen - 1151-1157 Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists
by Paolo Candio & Koen B. Pouwels & David Meads & Andrew J. Hill & Laura Bojke & Claire Williams - 1159-1171 Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study
by Hidetoshi Shibahara & Takeru Shiroiwa & Megumi Ishiguro & Masato Nakamura & Junichi Hasegawa & Shigeki Yamaguchi & Yuriko Masuda & Junichi Sakamoto & Naohiro Tomita & Takashi Fukuda - 1173-1185 Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom
by Sarkis Manoukian & Sally Stewart & Stephanie J. Dancer & Helen Mason & Nicholas Graves & Chris Robertson & Alistair Leonard & Sharon Kennedy & Kim Kavanagh & Benjamin Parcell & Jacqui Reilly - 1187-1201 Catastrophic household expenditure associated with out-of-pocket payments for dental healthcare in Spain
by Samuel López-López & Raúl Pozo-Rubio & Marta Ortega-Ortega & Francisco Escribano-Sotos - 1203-1220 Supply-side solutions targeting demand-side characteristics: causal effects of a chronic disease management program on adherence and health outcomes
by Luke Connelly & Gianluca Fiorentini & Marica Iommi - 1221-1227 Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
by Mohamed N. M. T. Al Khayat & Job F. H. Eijsink & Maarten J. Postma & Ewoudt M. W. Garde & Marinus Hulst - 1229-1242 Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality
by Christoph Strumann & Alexander Geissler & Reinhard Busse & Christoph Pross - 1243-1255 Measuring the acceptability of EQ-5D-3L health states for different ages: a new adaptive survey methodology
by Zoltán Hermann & Márta Péntek & László Gulácsi & Irén Anna Kopcsóné Németh & Zsombor Zrubka - 1257-1257 Correction to: Geographic distribution of physicians in Portugal
by Isabel Correia & Paula Veiga
August 2022, Volume 23, Issue 6
- 913-915 European union regulation of health technology assessment: what is required for it to succeed?
by Michael Drummond & Rosanna Tarricone & Aleksandra Torbica - 917-940 Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy
by Gaetano Perone - 941-952 Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system
by Qing Xia & Julie A. Campbell & Hasnat Ahmad & Barbara Graaff & Lei Si & Petr Otahal & Kevin Ratcliffe & Julie Turtle & John Marrone & Mohammed Huque & Barry Hagan & Matthew Green & Andrew J. Palmer - 953-968 Does compulsory schooling affect health? Evidence from ambulatory claims data
by Tatjana Begerow & Hendrik Jürges - 969-978 Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme
by Danny Wende & Dagmar Hertle & Claudia Schulte & Pedro Ballesteros & Uwe Repschläger - 979-991 Costing methodologies in European economic evaluation guidelines: commonalities and divergences
by Leticia García-Mochón & Zuzana Špacírová & Jaime Espín - 993-1005 The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study
by Sara Olofsson & Katarina Gralén & Christina Hoxer & Paul Okhuoya & Ulf Persson - 1007-1014 The remarkably frequent use of EQ-5D in non-economic research
by Aimin Wang & Kim Rand & Zhihao Yang & Richard Brooks & Jan Busschbach - 1015-1035 Income level and antibiotic misuse: a systematic review and dose–response meta-analysis
by Narmeen Mallah & Nicola Orsini & Adolfo Figueiras & Bahi Takkouche - 1037-1057 Willingness-to-pay for cancer treatment and outcome: a systematic review
by Alene Sze Jing Yong & Yi Heng Lim & Mark Wing Loong Cheong & Ednin Hamzah & Siew Li Teoh - 1059-1070 Value appropriation in hepatitis C
by Peter Lindgren & Sofia Löfvendahl & Gunnar Brådvik & Ola Weiland & Bengt Jönsson - 1071-1078 Decision thresholds with genetic testing
by Stefan Felder
July 2022, Volume 23, Issue 5
- 759-761 Seeking efficiency gains outside drugs and diagnostics
by Reyes Lorente & Fernando Antonanzas - 763-779 The cost-effectiveness of unilateral cochlear implants in UK adults
by Henry Cutler & Mutsa Gumbie & Emma Olin & Bonny Parkinson & Ross Bowman & Hafsa Quadri & Timothy Mann - 781-789 What drives variations in public health and social services expenditures? the association between political fragmentation and local expenditure patterns
by Yonsu Kim & Jae Hong Kim - 791-805 Adoption of large-scale medical equipment: the impact of competition in the German inpatient sector
by Marie Dreger & Hauke Langhoff & Cornelia Henschke - 807-821 Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
by Claudine Bommer & Judith Lupatsch & Nicole Bürki & Matthias Schwenkglenks - 823-835 Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland
by Stefania Di Gangi & Christophe Bagnoud & Giuseppe Pichierri & Thomas Rosemann & Andreas Plate - 837-846 Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
by Michaela Barbier & Nicholas Durno & Craig Bennison & Mathias Örtli & Christian Knapp & Matthias Schwenkglenks - 847-861 The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups
by Hirotaka Kato & Rei Goto & Taishi Tsuji & Katsunori Kondo - 863-878 Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
by Agnes Kisser & Joschua Knieriemen & Annette Fasan & Karolin Eberle & Sara Hogger & Sebastian Werner & Tina Taube & Andrej Rasch - 879-891 One last effort. Are high out-of-pocket payments at the end of life a fatality?
by Rosalind Bell-Aldeghi & Nicolas Sirven & Morgane Guern & Christine Sevilla-Dedieu - 893-901 Work ethics, stay-at-home measures and COVID-19 diffusion
by Vincenzo Alfano - 903-912 Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures
by Abdulrahman Jbaily & Annie Haakenstad & Mizan Kiros & Carlos Riumallo-Herl & Stéphane Verguet
June 2022, Volume 23, Issue 4
- 559-563 Microeconomics of intertemporal choice in zero-space during Covid-19: a behavioral economics perspective
by Javier Cifuentes-Faura & Renaud Francesco - 565-595 Short- and medium-term cost effects of non-indicated thyroid diagnostics: empirical evidence from German claims data
by Lucas Hafner & Valeria Biermann & Susann Hueber & Ewan Donnachie & Thomas Kühlein & Harald Tauchmann & Johanna Tomandl - 597-606 A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands
by Steef Redeker & Sohal Ismail & Hester V. Eeren & Emma K. Massey & Willem Weimar & Mark Oppe & Jan Busschbach - 607-615 Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
by Dan Cai & Si Shi & Shan Jiang & Lei Si & Jing Wu & Yawen Jiang - 617-625 Communities and testing for COVID-19
by Steven Stillman & Mirco Tonin - 627-643 Infections, accidents and nursing overtime in a neonatal intensive care unit
by Marc Beltempo & Georges Bresson & Jean-Michel Étienne & Guy Lacroix - 645-669 Consideration of quality of life in the health technology assessments of rare disease treatments
by Elena Nicod & Michela Meregaglia & Amanda Whittal & Sheela Upadhyaya & Karen Facey & Michael Drummond - 671-685 The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies
by Alessandra Cepparulo & Luisa Giuriato - 687-703 Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan
by Eyal Lahav & Shosh Shahrabani & Mosi Rosenboim & Yoshiro Tsutsui - 705-715 The impact of decentralisation on the performance of health care systems: a non-linear relationship
by Sean Dougherty & Luca Lorenzoni & Alberto Marino & Fabrice Murtin - 717-728 Using Australian panel data to account for unobserved factors in measuring inequities for different channels of healthcare utilization
by Jonas Fooken & Varinder Jeet - 729-753 The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes
by Eline Moens & Louis Lippens & Philippe Sterkens & Johannes Weytjens & Stijn Baert - 755-756 Demonstrating the value of cancer biomarkers at the population level
by Afschin Gandjour - 757-758 Reply to comment on “Demonstrating the value of cancer biomarkers at the population”
by Ana Beatriz D’Avó Luís & Mikyung Kelly Seo
April 2022, Volume 23, Issue 3
- 329-335 Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests
by Juan Llano & Jorge Mestre-Ferrandiz & Jaime Espin & Jordi Gol-Montserrat & Alicia Llano & Carlos Bringas - 337-356 Online and offline health information seeking and the demand for physician services
by Hiroaki Suenaga & Maria Rosalía Vicente - 357-374 Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)
by Lien Nguyen & Hanna Jokimäki & Ismo Linnosmaa & Eirini-Christina Saloniki & Laurie Batchelder & Juliette Malley & Hui Lu & Peter Burge & Birgit Trukeschitz & Julien Forder - 375-431 Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability
by Suaad Almajed & Nora Alotaibi & Sana Zulfiqar & Zahraa Dhuhaibawi & Niall O’Rourke & Richard Gaule & Caoimhe Byrne & Aaron M. Barry & Dylan Keeley & James F. O’Mahony - 433-451 A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)
by Darius N. Lakdawalla & Charles E. Phelps - 453-465 Does the amount of formal care affect informal care? Evidence among over-60s in France
by Elsa Perdrix & Quitterie Roquebert - 467-483 Income and conversion handicaps: estimating the impact of child chronic illness/disability on family income and the extra cost of child chronic illness/child disability in Ireland using a standard of living approach
by Áine Roddy - 485-497 The employment situation of people living with HIV: a closer look at the effects of the 2008 economic crisis
by Beatriz Rodríguez-Sánchez & Luz María Peña-Longobardo & Juan Oliva-Moreno - 499-510 The impact of inpatient bed capacity on length of stay
by Brendan Walsh & Samantha Smith & Maev-Ann Wren & James Eighan & Seán Lyons - 511-535 Retirement, social support and mental well-being: a couple-level analysis
by Nathan Kettlewell & Jack Lam - 537-549 Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK
by Ioanna Vlachaki & Daniela Zinzi & Edel Falla & Theo Mantopoulos & Holly Guy & Jasimran Jandu & Andrew Dodgson - 551-558 Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
by Laia Alsina & J. Bruno Montoro & Pedro Moral Moral & Olaf Neth & Marta Ortiz Pica & Silvia Sánchez-Ramón & María Presa & Itziar Oyagüez & Miguel Ángel Casado & Luis Ignacio González-Granado
March 2022, Volume 23, Issue 2
- 155-163 Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
by Elisabete Gonçalves - 165-176 Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A
by Richard Huan Xu & Anju Devianee Keetharuth & Ling-ling Wang & Annie Wai-ling Cheung & Eliza Lai-yi Wong - 177-192 The economic burden of obesity in Italy: a cost-of-illness study
by Margherita d’Errico & Milena Pavlova & Federico Spandonaro - 193-210 Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis
by Rachael Maree Hunter & Rob Anderson & Tim Kirkpatrick & Charlotte Lennox & Fiona Warren & Rod S. Taylor & Jenny Shaw & Mark Haddad & Alex Stirzaker & Mike Maguire & Richard Byng - 211-223 Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France
by Alexandre Vimont & Henri Leleu & Isabelle Durand-Zaleski - 225-235 Mapping of head and neck cancer patient concerns inventory scores on to Euroqol-Five Dimensions-Five Levels (EQ-5D-5L) health utility scores
by Krishnakumar Thankappan & Tejal Patel & Krishna Kollamparambil Ajithkumar & Deepak Balasubramanian & Manu Raj & Sujha Subramanian & Subramania Iyer - 237-248 Simulating lifestyle and medical interventions to prevent type-2 diabetes: an economic evaluation for Belgium
by Désirée Vandenberghe - 249-259 The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study
by Paul Hanly & Michelle Ahern & Linda Sharp & Diana Ursul & Gerard Loughnane - 261-275 Is prevention of suicide worth less? A comparison of the value per statistical life
by Vimefall Elin & Persson Mattias & Olofsson Sara & Hultkrantz Lars - 277-299 Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression
by Christian R. C. Kouakou & Thomas G. Poder - 301-312 The contribution of resident physicians to hospital productivity
by Maria J. Perez-Villadóniga & Ana Rodriguez-Alvarez & David Roibas - 313-327 Estimating the additional costs of living with a disability in the United Kingdom between 2013 and 2016
by Lukas Schuelke & Luke Munford & Marcello Morciano
February 2022, Volume 23, Issue 1
- 1-5 The Italian NHS at regional level: same in theory, different in practice
by Livio Garattini & Marco Badinella Martini & Michele Zanetti - 7-22 Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China
by Wen He - 23-32 Costs and management of patients with hemophilia A in France: the Hemraude study
by C. Laurendeau & J. Goudemand & M. Trossaert & B. Polack & R. Varin & C. Godard & F. Hadim & B. Detournay - 33-45 Production losses due to mortality associated with modifiable health risk factors in Poland
by Błażej Łyszczarz & Karolina Sowa - 47-57 HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm
by Ana Sofia Oliveira Gonçalves & Dimitra Panteli & Lars Neeb & Tobias Kurth & Annette Aigner - 59-65 Effects of provider incentives on dental X-raying in NHS Scotland: what happens if patients switch providers?
by Olivier Kalmus & Martin Chalkley & Stefan Listl - 67-80 The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study
by Josephine Storch & Carolin Fleischmann-Struzek & Norman Rose & Thomas Lehmann & Anna Mikolajetz & Srikanth Maddela & Mathias W. Pletz & Christina Forstner & Ole Wichmann & Julia Neufeind & Monique Vogel & Konrad Reinhart & Horst Christian Vollmar & Antje Freytag - 81-94 Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?
by Sebastian Himmler & Job Exel & Werner Brouwer - 95-104 The impact of cancellations in waiting times analysis: evidence from scheduled surgeries in the Portuguese NHS
by Joana Cima & Álvaro Almeida - 105-117 Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis
by Amit Summan & Arindam Nandi - 119-131 Health effects from heat waves in France: an economic evaluation
by Lucie Adélaïde & Olivier Chanel & Mathilde Pascal - 133-151 Use of past care markers in risk-adjustment: accounting for systematic differences across providers
by Laura Anselmi & Yiu-Shing Lau & Matt Sutton & Anna Everton & Rob Shaw & Stephen Lorrimer - 153-153 Correction to: The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study
by Paul Hanly & Michelle Ahern & Linda Sharp & Diana Ursul & Gerard Loughnane
December 2021, Volume 22, Issue 9
- 1345-1348 Pricing vaccines and drugs in Europe: worth differentiating?
by Livio Garattini & Anna Padula & Nicholas Freemantle - 1349-1363 The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups
by V. Lorenzoni & G. Barbieri & F. Saia & F. Meucci & G. L. Martinelli & A. G. Cerillo & S. Berti & P. Candolfi & G. Turchetti - 1365-1370 Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis
by Ian Grady & Sean Grady & Nailya Chanisheva - 1371-1379 Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
by A. Marcellusi & F. S. Mennini & P. Sciattella & G. Favato - 1381-1391 Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly
by Kailu Wang & Xiaopeng Guo & Siyue Yu & Lu Gao & Zihao Wang & Huijuan Zhu & Bing Xing & Shuyang Zhang & Dong Dong - 1393-1409 The effects of health shocks on family status: do financial incentives encourage marriage?
by Andree Ehlert - 1411-1425 Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana
by Isaac Koomson & Abdallah Abdul-Mumuni & Anthony Abbam - 1427-1439 Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues
by Ugur Korkut Pata - 1441-1451 Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial
by Nathan S. McClure & Mike Paulden & Arto Ohinmaa & Jeffrey A. Johnson - 1453-1466 Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population
by Petra Baji & Miklós Farkas & Ágota Dobos & Zsombor Zrubka & Levente Kovács & László Gulácsi & Márta Péntek - 1467-1475 General population normative data for the EQ-5D-3L in the five largest European economies
by Mathieu F. Janssen & A. Simon Pickard & James W. Shaw - 1477-1485 A direct method for the identification of patterns of care using administrative databases: the case of breast cancer
by Susanna Busco & Andrea Tavilla & Anna Gigli & Tania Lopez & Daniela Pierannunzio & Sandra Mallone & Stefano Guzzinati & Giulia Capodaglio & Francesco Giusti & Catia Angiolini & Silvia Francisci - 1487-1505 The costs of celiac disease: a contingent valuation in Switzerland
by Laia Soler & Nicolas Borzykowski - 1507-1518 Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states
by S. A. Lipman & V. T. Reckers-Droog & M. Karimi & M. Jakubczyk & A. E. Attema - 1519-1533 The effect of mental and physical health problems on sickness absence
by Mark L. Bryan & Andrew M. Bryce & Jennifer Roberts
November 2021, Volume 22, Issue 8
- 1141-1150 Structural factors and integrated care interventions: is there a role for economists in the policy debate?
by Luke B. Connelly & Gianluca Fiorentini - 1151-1166 The economic burden of amyotrophic lateral sclerosis: a systematic review
by K. Achtert & L. Kerkemeyer - 1167-1181 Complements or substitutes? Associations between volumes of care provided in the community and hospitals
by Yiu-Shing Lau & Gintare Malisauskaite & Nadia Brookes & Shereen Hussein & Matt Sutton - 1183-1194 Unpacking the red packets: institution and informal payments in healthcare in China
by Ning Liu & Zhuo Chen & Guoxian Bao - 1195-1216 Does waiting times decrease or increase operational costs in short and long-term? Evidence from Portuguese public hospitals
by André Madeira & Victor Moutinho & José Alberto Fuinhas - 1217-1237 The role of health at birth and parental investment in early child development: evidence from the French ELFE cohort
by Marion Davin & Emmanuelle Lavaine - 1239-1251 On the correlation between outcome indicators and the structure and process indicators used to proxy them in public health care reporting
by Benjamin H. Salampessy & France R. M. Portrait & Eric Hijden & Ab Klink & Xander Koolman - 1253-1273 Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges
by Carlo Federici & Vivian Reckers-Droog & Oriana Ciani & Florian Dams & Bogdan Grigore & Zoltán Kaló & Sándor Kovács & Kosta Shatrov & Werner Brouwer & Michael Drummond - 1275-1288 Health state utility values by cancer stage: a systematic literature review
by Mir-Masoud Pourrahmat & Ashley Kim & Anuraag R. Kansal & Marg Hux & Divya Pushkarna & Mir Sohail Fazeli & Karen C. Chung - 1289-1299 Business cycle and mortality in Spain
by María Cervini-Plá & Judit Vall-Castelló - 1301-1309 Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
by Koonal K. Shah & Bryan Bennett & Andrew Lenny & Louise Longworth & John E. Brazier & Mark Oppe & A. Simon Pickard & James W. Shaw - 1311-1344 Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies
by Nikolai Mühlberger & Gaby Sroczynski & Artemisa Gogollari & Beate Jahn & Nora Pashayan & Ewout Steyerberg & Martin Widschwendter & Uwe Siebert
September 2021, Volume 22, Issue 7
- 1001-1004 COVID-19: not the time for health economists? A plea for more proactive health economic involvement
by J.-Matthias Graf von der Schulenburg - 1005-1016 How the COVID-19 pandemic can distort risk adjustment of health plan payment
by Richard C. Kleef & Mieke Reuser - 1017-1024 The impact of COVID-19 pandemic on insurance demand: the case of China
by Xianhang Qian - 1025-1038 Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections
by Donatella Saccone - 1039-1052 Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study
by Audrey Tanguy-Melac & Dorian Verboux & Laurence Pestel & Anne Fagot-Campagna & Philippe Tuppin & Christelle Gastaldi-Ménager - 1053-1065 Economics of mental well-being: a prospective study estimating associated health care costs and sickness benefit transfers in Denmark
by Ziggi Ivan Santini & Hannah Becher & Maja Bæksgaard Jørgensen & Michael Davidsen & Line Nielsen & Carsten Hinrichsen & Katrine Rich Madsen & Charlotte Meilstrup & Ai Koyanagi & Sarah Stewart-Brown & David McDaid & Vibeke Koushede - 1067-1081 What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?
by Tessa Peasgood & Clara Mukuria & Jill Carlton & Janice Connell & Nancy Devlin & Karen Jones & Rosemary Lovett & Bhash Naidoo & Stacey Rand & Juan Carlos Rejon-Parrilla & Donna Rowen & Aki Tsuchiya & John Brazier - 1083-1093 Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China
by Wang Pei & Sun Yue & Yang Zhi-Hao & Zhang Ruo-Yu & Wu Bin & Luo Nan - 1095-1101 Obesity Kuznets curve and the reality of eco-income ellipsoids (EIE)
by Andrew Adewale Alola & Festus Victor Bekun - 1103-1113 Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies
by Wenjing Zhou & Anle Shen & Zhihao Yang & Pei Wang & Bin Wu & Michael Herdman & Nan Luo - 1115-1128 Assessing the consequences of quarantines during a pandemic
by Rikard Forslid & Mathias Herzing - 1129-1139 The relationship between renewable energy use and health expenditures in EU countries
by Mahmut Unsal Sasmaz & Aysun Karamıklı & Ulas Akkucuk
August 2021, Volume 22, Issue 6
- 851-854 Something borrowed, something new: measuring hospital performance in the context of value based health care
by Peter Lindgren & Rikard Althin - 855-864 Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
by Arnaud Bayle & N. Droin & B. Besse & Z. Zou & Y. Boursin & S. Rissel & E. Solary & L. Lacroix & E. Rouleau & I. Borget & J. Bonastre - 865-872 Comparison of self-reported and public registered absenteeism among people on long-term sick leave due to musculoskeletal disorders: criterion validity of the iMTA Productivity Cost Questionnaire
by Rikke Munk Killingmo & Anne Therese Tveter & Milada C. Småstuen & Kjersti Storheim & Margreth Grotle - 873-885 Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data
by Claudia Schulz & Gisela Büchele & Raphael S. Peter & Dietrich Rothenbacher & Christian Brettschneider & Ulrich C. Liener & Clemens Becker & Kilian Rapp & Hans-Helmut König - 887-903 Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary
by Anikó Bíró & Ágnes Szabó-Morvai - 905-915 The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary
by Christoph F. Kurz & Adriana N. König - 917-929 Regional medical practice variation in high-cost healthcare services
by Michael Berger & Thomas Czypionka - 931-949 Using fees to reduce bed-blocking: a game between hospitals and long-term care providers
by Snorre Kverndokk & Hans Olav Melberg - 951-960 Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits
by Ruben Willems & Fouke Ombelet & Eva Goossens & Katya De Groote & Werner Budts & Stéphane Moniotte & Michèle de Hosson & Liesbet Van Bulck & Ariane Marelli & Philip Moons & Julie De Backer & Lieven Annemans - 961-975 Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review
by Kristina Kast & Carl-Philipp Wachter & Oliver Schöffski & Martina Rimmele - 977-989 Home sweet home: GPs’ response to an increase in the fee size for home visits
by Jamie O’Halloran & Anne Sophie Oxholm & Line Bjørnskov Pedersen & Dorte Gyrd-Hansen - 991-999 Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
by Marije E. Hagendijk & Simon Schans & Cornelis Boersma & Maarten J. Postma & Simon Pol
July 2021, Volume 22, Issue 5
- 661-667 The “red herring” after 20 years: ageing and health care expenditures
by Friedrich Breyer & Normann Lorenz - 669-677 A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland
by Michaela Carla Barbier & Esther Pardo & Cédric Michael Panje & Oliver Gautschi & Judith Eva Lupatsch - 679-697 Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others
by Sebastian Neumann-Böhme & Stefan A. Lipman & Werner B. F. Brouwer & Arthur E. Attema - 699-709 How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach
by Shuli Brammli-Greenberg & Ira Yaari & Elad Daniels & Ariella Adijes-Toren - 711-721 Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses
by Mark Oppe & Daniela Ortín-Sulbarán & Carlos Vila Silván & Anabel Estévez-Carrillo & Juan M. Ramos-Goñi - 723-733 Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists
by Michael J. Zoratti & A. Simon Pickard & Peep F. M. Stalmeier & Daniel Ollendorf & Andrew Lloyd & Kelvin K W Chan & Don Husereau & John E. Brazier & Murray Krahn & Mitchell Levine & Lehana Thabane & Feng Xie - 735-747 Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients
by Asrul Akmal Shafie & Irwinder Kaur Chhabra & Jacqueline Hui Yi Wong & Noor Syahireen Mohammed